Comment from Kyle Cothern
Kyle CothernOpposeIndividual
Summary: The commenter opposes the potential ban or reclassification of peptides, arguing that they are affordable and improve the quality of life for many patients. They claim the action is driven by "big pharma" lobbying and greed rather than public health concerns.
The possible ban of peptides is unbelievable. Those drugs improve quality of life for so many and are a very affordable option compared to other drugs that allegedly have similar effects. The fact they could be moved to a different schedule and demonized when they have so many benefits is very telling. The FDA is getting their pockets lined by big pharma to ban these drugs. It is so obvious the lobbying going on, all out of pure greed. Do the right thing.